Literature DB >> 8699769

[Dermal fat transplant as autologous orbital implant].

C R Hintschich1, C K Beyer-Machule.   

Abstract

BACKGROUND: The use of orbital implants after an enucleation is the pre-condition for an adequate fitting of the prosthesis and gives the best functional and cosmetic results. The autogenous dermofat graft is an alternative to the widely used alloplastic orbital implants. It can be used as a primary implant or as a secondary implant for the correction of a contracted socket or a post enucleation socket syndrome.
METHOD: Deepithelialized skin with subcutaneous fat is implanted into the socket. The rectus muscles, Tenon's capsule and conjunctive are fixed to the transplant separately. Surgical technique, possible complications and their therapy are presented.
CONCLUSIONS: Disadvantages of the method are the more extensive surgery, some minor complications and the possible shrinkage of the transplant. Advantageous is the fact, that typical complications of all alloplastic implants, like migration and extrusion, can be avoided, heterologous materials like donor sclera are unnecessary and the functional and cosmetic results are very good.

Entities:  

Mesh:

Year:  1996        PMID: 8699769     DOI: 10.1055/s-2008-1035186

Source DB:  PubMed          Journal:  Klin Monbl Augenheilkd        ISSN: 0023-2165            Impact factor:   0.700


  4 in total

1.  [Dermis-fat graft. Possibilities and limitations].

Authors:  C Hintschich
Journal:  Ophthalmologe       Date:  2003-07-01       Impact factor: 1.059

Review 2.  [Ocular prosthetics. Fitting, daily use and complications].

Authors:  K R Koch; W Trester; N Müller-Uri; M Trester; C Cursiefen; L M Heindl
Journal:  Ophthalmologe       Date:  2016-02       Impact factor: 1.059

3.  [Dermofat grafting].

Authors:  C Hintschich
Journal:  Ophthalmologe       Date:  2017-08       Impact factor: 1.059

Review 4.  Survey on the management of orbital and intraocular tumors among oculofacial surgeons in the Asia-Pacific region.

Authors:  Priscilla Xinhui Wang; Victor Teck Chang Koh; Katherine Lun; Gangadhara Sundar
Journal:  Int Ophthalmol       Date:  2013-10-02       Impact factor: 2.031

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.